Clinical Trials Directory

Trials / Unknown

UnknownNCT03379857

Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Incidence of strokes has increased these last 20 years in young population. This rise could be linked to alcohol, tobacco or drug use like cannabis. Cannabis has previously been descripted as a potential factor of reversible vasoconstriction. The main objective is to show that an exhaustive assessment of a stroke facing a young person frequently lead to a diagnostic of reversible vasoconstriction due to cannabis use. Evaluation will focus on prevalence of strokes secondary to a reversible vasoconstriction attributable to cannabis in young subjects. There's a real public healthcare interest in terms of primary and secondary prevention to evaluate the role of cannabis as a risk factor of stroke in young population.

Conditions

Interventions

TypeNameDescription
OTHERDrug urinal testNon Applicable

Timeline

Start date
2018-01-11
Primary completion
2025-01-11
Completion
2025-01-11
First posted
2017-12-20
Last updated
2024-02-20

Locations

6 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03379857. Inclusion in this directory is not an endorsement.